BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 8, 2010
View Archived Issues
Prucalopride is safe and efficacious in opioid-induced constipation
Read More
Amantadine and fluoxetine display comparable efficacy in major depressive disorder
Read More
Technetium-99m-labeled MIP-1340 shows suitability for prostate cancer imaging
Read More
Banyu Pharmaceutical discloses new DGAT-1 inhibitors
Read More
OriBase Pharma describes new tyrosine protein kinase inhibitors
Read More
Italian scientists synthesize new HDAC inhibitor
Read More
Ivabradine improves outcome of patients with heart failure in SHIFT trial
Read More
BioFocus and Usher III Initiative partner to discover drugs for Usher's syndrome type III
Read More
AstraZeneca identifies new histamine H3 receptor antagonists
Read More
CytRx begins phase II bafetinib trial in advanced prostate cancer
Read More
Shionogi claims new P2X3 and P2X2/3 receptor antagonists
Read More
Rexahn submits protocol to FDA for phase IIb RX-10100 trial
Read More
Arrow Therapeutics discloses new antivirals for HCV infection
Read More
La Jolla Pharma seeks candidate small-molecule therapeutics to inlicense or acquire
Read More
Promedior begins phase IIa trial of PRM-151 for postsurgical scarring in glaucoma
Read More
Somaxon launches Silenor in U.S. for insomnia
Read More
FDA clears IND for Tekmira's TKM-PLK1
Read More
Enrollment reinitiated in phase III trial of zanolimumab in CTCL
Read More
Merz Pharma Canada's Xeomin to be listed with regular benefit status
Read More
Idenix's IDX-184 and IDX-320 programs in HCV infection on clinical hold
Read More
Phase III REALIZE trial of telaprevir in HCV infection meets primary endpoint
Read More
Onyx and Ono sign Japanese agreements for oncology drugs carfilzomib and ONX-0912
Read More
Thomson Reuters salutes winner of 2010 IUPAC-Richter Prize in Medicinal Chemistry
Read More
Can-Fite files IND application for phase III CF-101 trial in dry eye syndrome
Read More
Abbott acquires Piramal's Healthcare Solutions business
Read More